Drug Approval | July 17, 2025
Shilpa Medicare receives EIR from USFDA for Unit VI, Bengaluru
This facility is capable of manufacturing, packaging, testing, storage and distribution of two types of complex dosage forms
This facility is capable of manufacturing, packaging, testing, storage and distribution of two types of complex dosage forms
The receipt of EIR reaffirms the company's commitment to maintaining global quality standards
Plant-based chemistries have an outsized role to play for the HPC sector by meeting demand for good, gentle, and green products
Godavari Biorefineries receives patent from CNIPA
The agreement includes plans for distribution, technology transfer, local manufacturing, new pharmaceutical product development
Capricor’s BLA for Deramiocel received Priority Review in March 2025
Havix is a US based company engaged in the business of developing, manufacturing and supplying of various finished formulations
The company’s largest center for medical device applications, serving the entire Asian market
Emcure Pharmaceuticals successfully completes USFDA PAI of Oncology facility
This year, 40 women students are participating, selected through a rigorous process evaluating academic merit, research interest, and socio-economic background
Subscribe To Our Newsletter & Stay Updated
